Chad Mirkin, winner of the 2009 $500,000 Lemelson-MIT Prize, presents the development of Nanoparticle-based biodiagnostics and the barcode assay to diagnose patients at early stages of disease and his invention of Dip-Pen Nanolithography used to fabricate nanostructures.